Research and Forecast of China IVD Reagent (In Vitro Diagnostic Reagent) Industry, 2014-2018 mainly conducts in-depth analysis on the external environment, market operation, import & export of China’s IVD reagent industry, and also summaries the latest development of key Chinese domestic enterprises in 2013, and finally forecasts the future industrial development. The information can offer investors the decisive reference for their investment in the field.
IVD reagent industry is an emerging industry in China, the start is late and the development is relatively backward compares with occidental countries. According to the data provided by IVD Special Committee, there are 300 to 400 IVD reagent manufacturing enterprises in China, of which, 200 enterprises own above designated scale. However, only about 20 enterprises have the ability to achieve annual sales income of more than CNY 100 million; most of enterprises are in small scale and the product variety is few.
In 2013, the market scale of China’s IVD industry reached CNY 22.5 billion; among them, the market scale of IVD reagents was about CNY 16.3 billion.
The state policy encourages the competitive enterprises to strengthen their strength. In 2013, a series of policies which target to improve industry standard and threshold entered the substantive operation stage, which accelerates the elimination of small enterprises and improves the industry concentration ratio. Industrial consolidation is the development trend, and the enterprises with capital, technology and scale advantages will win gradually.
In recent years, due to the continued sluggishness of European and American pharmaceutical market, the international giants target on the market expansion brought by China’s new medical reform, and entered China’s market in succession; after the China-oriented R&D center transfer, these powerful enterprises began to compete with China’s enterprises in the low and medium-end markets through mergers, acquisitions, capital increase and production expansion; therefore, the competitive enterprises in China’s diagnostic reagent subdivided industries will face more sever competitions.
1. Overview of Diagnostic Reagent Industry
1.1 Definition and Classification
1.1.1 Definition and Classification of Biological Products
1.1.2 Definition and Classification of IVD Reagents
1.2 Development History
1.3 Industry Chain
1.4 Overview of Main Sub-industries
1.4.1 Bio7 Diagnostic Reagent Industry
1.4.2 Immune Diagnostic Reagent Industry
1.4.3 Molecular Diagnostic Reagent Industry
2. Operating Environment of China’s IVD Reagent Industry
2.1 Development Overview of Global IVD Reagent Industry
2.2 Development Overview of China’s Bio-pharmaceutical Industry
2.3 National Related Industry Management and Policy
2.3.1 Industry Competent Departments
2.3.2 Industry Supervision System
2.3.3 Main Laws and Regulations
2.3.4 Main Industry Policies
3. Operation State of China’s IVD Reagent Market
3.1 Development Status
3.2.1 Overall Market Demand
3.2.2 Application Status and Development Trend of Main Varieties
3.3 Competitive Pattern
3.4 Barriers to Entry
3.4.1 Technology Barrier
3.4.2 Quality and Brand Barrier
3.4.3 Marketing Channel Barrier
3.4.4 Market Access Barrier
3.5 Profit Level and Variation Trend
3.6 Adverse Factors for the Industry Development
3.6.1 Low Market Concentration Ratio; Serious Product Homogeneity
3.6.2 Relatively Low Overall R&D Investment Level
3.6.3 International Giants Occupying Dominant Positions in China’s High-end Market
3.7 Technological Level and Business Model
3.7.1 Technological Level and Development Trend
3.7.2 Characteristics of Business Model
3.8 Periodical, Regional and Seasonal Characteristics
3.8.2 Regional Nature
3.9 Relevance and Influence of Upstream Industries and Downstream Industries to the IVD Reagent Industry
3.9.1 Upstream Raw Materials Mainly Depending on Imports
3.9.2 Downstream Demands Showing the Rigidity
3.9.3 Relevance with the IVD Instrument Industry
4. Import and Export of China’s IVD Reagent Industry
5. China’s Key IVD Reagent Enterprises
5.1 Shanghai Kehua Bio-engineering Co., Ltd.
5.1.1 Company Profile
5.1.2 Operating Conditions
5.1.3 Core Competitiveness
5.1.4 R & D Project, Business Plan and Future Development Strategy, 2013
5.2 DAAN Gene Co., Ltd.
5.2.1 Company Profile
5.2.2 Business Development
5.2.3 Main Business Composition
5.2.4 Core Competitiveness
5.2.5 Acquiring the Official Approval of Ministry of Finance, Equity Incentive Plan Getting Great Progress
5.3 Shanghai Fosun Pharmaceutical (Group) CO., Ltd.
5.3.1 Company Profile
5.3.2 Main Business Composition
5.3.3 Development of Medical Diagnosis and Medical Device Business
5.4 BioSino Bio-technology and Science Inc.
5.4.1 Company Profile
5.4.2 Operating Conditions
5.4.3 Future Development Strategy
5.5 Beijing Leadman Biochemistry Co., Ltd.
5.5.1 Company Profile
5.5.2 Operating Conditions
5.5.3 Main Business Composition
5.6 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
5.6.1 Company Profile
5.6.2 Operating Conditions
5.7.1 Company Profile
5.7.2 Operating Conditions
5.7.3 Business Development
5.8 Zhejiang DIAN Diagnosis Co., Ltd. (DIAN Diagnosis)
5.8.1 Company Profile
5.8.2 Business Development
5.8.3 Main Business Composition
6. Future Development of China’s IVD Reagent Industry
6.1 Development Trends
6.3 Growth Forecast of Market Scale, 2014-2018